Fortrea Holdings (FTRE) Assets Average (2023 - 2026)
Fortrea Holdings (FTRE) reported Assets Average of $2.7 billion for Q1 2026, down 19.42% on a YoY basis from $3.4 billion in Q1 2025, and down 1.08% quarter-over-quarter from $2.7 billion in Q4 2025.
Fortrea Holdings (FTRE) Assets Average (2023 - 2026) Analysis & Trends
Fortrea Holdings has reported Assets Average for 4 years, with the latest figure at $2.7 billion in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 19.42% year-over-year to $2.7 billion; the trailing twelve-month figure through Mar 2026 stood at $2.7 billion (down 19.42% YoY), and the FY2025 full-year result was $3.1 billion, down 20.44% from the prior year.
- Assets Average for Q1 2026 stood at $2.7 billion, down from $2.7 billion in the prior quarter.
- The five-year high for Assets Average was $4.3 billion in Q3 2023, with the low at $2.7 billion in Q1 2026.
- Historically, Assets Average has averaged $3.5 billion across 4 years, with a median of $3.6 billion in 2024.
- Annual changes were most pronounced in 2024 — Assets Average slipped 16.26% — and 2025, when it decreased 24.65%.
- Fortrea Holdings' Assets Average stood at $4.3 billion in 2023, then slipped by 16.26% to $3.6 billion in 2024, then decreased by 24.65% to $2.7 billion in 2025, then declined by 1.08% to $2.7 billion in 2026.
- The last three Assets Average figures came in at $2.7 billion (Q1 2026), $2.7 billion (Q4 2025), and $2.8 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | 2.70 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.70 Bn |
| Dec 31, 2025 | 2.73 Bn |
| Sep 30, 2025 | 2.79 Bn |
| Jun 30, 2025 | 2.98 Bn |
| Mar 31, 2025 | 3.35 Bn |
| Dec 31, 2024 | 3.62 Bn |
| Sep 30, 2024 | 3.61 Bn |
| Jun 30, 2024 | 3.90 Bn |
| Mar 31, 2024 | 4.29 Bn |
| Dec 31, 2023 | 4.32 Bn |
| Sep 30, 2023 | 4.34 Bn |